Literature DB >> 7828612

Functional neuroimaging in Alzheimer's disease: how far should we go?

R Kerwin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7828612     DOI： 10.1007/bf00181057

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


× No keyword cloud information.
  9 in total

Review 1.  New drug interventions in Alzheimer's disease.

Authors:  G M Stern
Journal:  Curr Opin Neurol Neurosurg       Date:  1992-02

2.  SPECT brain imaging in Alzheimer's disease during treatment with oral tetrahydroaminoacridine and lecithin.

Authors:  M B Cohen; L J Fitten; R R Lake; K M Perryman; L S Graham; R Sevrin
Journal:  Clin Nucl Med       Date:  1992-04       Impact factor: 7.794

3.  The investigation of Alzheimer's disease with single photon emission tomography.

Authors:  A Burns; M P Philpot; D C Costa; P J Ell; R Levy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

4.  The pattern of function-related regional cerebral blood flow investigated by single photon emission tomography with 99mTc-HMPAO in patients with presenile Alzheimer's disease and Korsakoff's psychosis.

Authors:  R Hunter; R McLuskie; D Wyper; J Patterson; J E Christie; D N Brooks; J McCulloch; G Fink; G M Goodwin
Journal:  Psychol Med       Date:  1989-11       Impact factor: 7.723

5.  Tacrine in Alzheimer's disease. Time course of changes in cognitive function and practice effects.

Authors:  S Eagger; N Morant; R Levy; B Sahakian
Journal:  Br J Psychiatry       Date:  1992-01       Impact factor: 9.319

6.  (99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type.

Authors:  U Spampinato; M O Habert; J L Mas; M C Bourdel; M Ziegler; J de Recondo; S Askienazy; P Rondot
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

7.  Assessment of cerebral perfusion with single-photon emission tomography in normal subjects and in patients with Alzheimer's disease: effects of region of interest selection.

Authors:  J J Claus; F van Harskamp; M M Breteler; E P Krenning; T J van der Cammen; A Hofman; D Hasan
Journal:  Eur J Nucl Med       Date:  1994-10

8.  HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.

Authors:  R Mielke; U Pietrzyk; A Jacobs; G R Fink; A Ichimiya; J Kessler; K Herholz; W D Heiss
Journal:  Eur J Nucl Med       Date:  1994-10

9.  Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer disease.

Authors:  D P Geaney; N Soper; B J Shepstone; P J Cowen
Journal:  Lancet       Date:  1990-06-23       Impact factor: 79.321
  9 in total
  1 in total

1.  A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia?

Authors:  P R Talbot; J J Lloyd; J S Snowden; D Neary; H J Testa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-03       Impact factor: 10.154
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.